Immunotec Inc

Immunotec Inc is dedicated to health and wellness, specializing in immune system support through scientifically crafted products designed to enhance overall vitality and athletic performance. Immunotec Inc, founded in 1996, is headquartered in Vaudreuil-Dorion, Canada. The company focuses on developing health products that support immune function. In March 2017, Nexxus Capital acquired a minority stake in the company, enhancing its operational capacity.

The current CEO is Mauricio Domenzain. Immunotec specializes in health and wellness products, focusing on immune support through its scientifically formulated offerings. Their flagship product, Immunocal®, is a natural protein that raises glutathione levels, crucial for immune function and detoxification. Other offerings include Immunocal Platinum, aimed at healthy aging, and Immunocal Sport, designed for athletic performance.

The product line also includes Superfood Reds & Greens Booster and Immunocal Booster Energy Performance, sold in 14 countries, including the USA and Canada, targeting health-conscious consumers and athletes. In the most recent fiscal year of 2016, Immunotec reported revenue of USD 36. 99 mn and an EBITDA of USD 755,000. Their revenue model primarily involves direct-to-consumer sales through subscriptions and one-time purchases.

Pricing for key products includes Immunocal at USD 112. 00, Immunocal Platinum at USD 164. 00, and Immunocal Sport at USD 169. 00, with discounts for regular subscribers.

Immunotec plans to leverage its recent funding from the minority stake acquisition in March 2017 to launch new products and expand into additional markets. Specific upcoming products and their launch dates have not been disclosed, but the company aims to explore growth opportunities in new geographic regions, including Europe and Asia, by mid-2025.